公开(公告)号：US12127916B2

公开(公告)日：2024-10-29

申请号：US16755814

申请日：2018-08-29

Applicant: Solventum Intellectual Properties Company

Inventor： Christopher Brian Locke ,  Justin Alexander Long ,  Benjamin Locke ,  Benjamin Andrew Pratt ,  Thomas Alan Edwards

IPC: A61F13/05 ,  A61F13/00 ,  A61M1/00

CPC classification number: A61F13/05 ,  A61M1/913 ,  A61F2013/00246 ,  A61M1/915 ,  A61M1/916

Abstract: An evaporative bridge dressing that may be used with negative-pressure treatment of tissue. The evaporative bridge dressing may have one or more fluid transfer layers comprised of high-density wicking material enclosed between layers of film having high moisture-vapor transfer rates to reduce liquid storage and minimize pressure drop.

公开(公告)号：US12274823B2

公开(公告)日：2025-04-15

申请号：US18134937

申请日：2023-04-14

Applicant: Solventum Intellectual Properties Company

Inventor： Christopher Brian Locke ,  Justin Alexander Long ,  Benjamin Locke ,  Benjamin Andrew Pratt ,  Thomas Alan Edwards ,  Timothy Mark Robinson

IPC: A61F13/01 ,  A61M1/00 ,  A61F13/05

Abstract: In some illustrative examples, a bridge suitable for treating a tissue site may include a bridge sealing member and one or more bridge wicking layers. The bridge sealing member may extend along a length of the bridge, and may define an internal passageway in fluid communication between a receiving end of the bridge and a transmitting end of the bridge. The one or more bridge wicking layers may be disposed within the internal passageway of the bridge sealing member. Other apparatus, systems, and methods are disclosed.

公开(公告)号：US12239779B2

公开(公告)日：2025-03-04

申请号：US17599855

申请日：2020-03-20

Applicant: Solventum Intellectual Properties Company

Inventor： Benjamin Andrew Pratt ,  Justin Rice ,  Thomas Alan Edwards ,  Christopher Allen Carroll

IPC: A61M1/00 ,  A61F13/05 ,  A61M3/02 ,  A61M39/22

Abstract: Disclosed embodiments relate to devices and systems for providing both negative-pressure therapy and instillation, In some embodiments, both negative-pressure and instillation may be provided to a tissue site in a low-profile context that may also prevent siphoning of instillation fluid during negative pressure application. For example, a single bridge may include a negative-pressure pathway with supports and an instillation pathway, and the instillation pathway may be configured with respect to the negative-pressure pathway so that at least a portion of the instillation pathway collapses upon application of negative pressure to the negative-pressure pathway. Collapse of at least a portion of the instillation pathway may be sufficient to close the instillation pathway.